GXP

Assessing Non-endotoxin Microbial Pyrogens in Relation in Pharmaceutical Processing | IVT

This article considerS pyrogens of microbial origin and the theoretical risks they pose to pharmaceutical products. The focus of the article IS with non-endotoxin pyrogens. The reasons for this are because of the voluminous content written about endotoxins and because non-endotoxin pyrogens often receive little discussion. Despite the low risk posed by non-endotoxin pyrogens, questions of their occurrence and risks are sometimes raised by regulators through inspections and by assessors during license changes and submissions. When such questions arise the pharmaceutical manufacturer is often called upon to undertake a risk assessment. Some of the information outlined within this article could be helpful in developing such an assessment.

This content is only available to IVT members.
Get help maintaining your knowledge in GXP. Read More!

If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.




Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.